IMA ImageneBio Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: IMA

Price (delayed)

$4.84

Market cap

$54.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.15

Enterprise value

-$37.82M

?
Relative Growth: Rel. Growth: 22
Relative Strength: Rel. Strength: 19
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2
Highlights
The EPS has soared by 70% year-on-year and by 48% since the previous quarter
The debt has dropped by 66% year-on-year and by 21% since the previous quarter
The net income has dropped by 142% year-on-year and by 5% since the previous quarter
The gross profit has shrunk by 100% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://ikenaoncology.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of IMA

IMA stock price

How has the ImageneBio stock price performed over time
Intraday
-0.21%
1 week
-1.83%
1 month
-12.16%
1 year
-39.12%
YTD
-29.86%
QTD
-17.97%

Financial performance

How have ImageneBio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$58.96M
Net income
-$52.48M
Gross margin
N/A
Net margin
N/A
The operating income has dropped by 174% year-on-year and by 8% since the previous quarter
The net income has dropped by 142% year-on-year and by 5% since the previous quarter
The gross profit has shrunk by 100% YoY
The revenue has dropped by 100% year-on-year

Price vs fundamentals

How does IMA's price correlate with its fundamentals

Growth

What is ImageneBio's growth rate over time

Valuation

What is ImageneBio stock price valuation
P/E
N/A
P/B
0.38
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 70% year-on-year and by 48% since the previous quarter
IMA's price to book (P/B) is 57% lower than its 5-year quarterly average of 0.9 and 2.5% lower than its last 4 quarters average of 0.4
The equity has grown by 23% YoY and by 15% from the previous quarter
The revenue has dropped by 100% year-on-year

Efficiency

How efficient is ImageneBio business performance
ImageneBio's return on equity has increased by 39% YoY and by 6% QoQ
IMA's return on invested capital is down by 15% since the previous quarter
ImageneBio's return on assets has decreased by 10% YoY but it has increased by 5% QoQ

Dividends

What is IMA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IMA.

Financial health

How did ImageneBio financials performed over time
The current ratio has soared by 59% YoY and by 17% from the previous quarter
IMA's quick ratio has soared by 59% YoY and by 17% from the previous quarter
The debt is 99% smaller than the equity
The debt to equity has plunged by 80% YoY and by 50% from the previous quarter
The debt has dropped by 66% year-on-year and by 21% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.